Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century. The Company's extensive European experience, fully integrated infrastructure, and exceptional partnership approach allow it to quickly apply creative solutions to bring patients life-changing medicines that they may not otherwise be able to access. Norgine is proud to have helped 24 million patients around the world in 2021 and generated €505 million in net product sales, representing growth of 10% over 2020. Norgine has a direct presence in 16 European countries, as well as Australia and New Zealand, and employs over 1,500 people. Norgine and the sail logo are trademarks of the Norgine group of companies.